# US 2015/0177133 A1 · Tomographic phase microscopy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0177133 A1
- Document ID: US20150177133A1
- Status: Published application
- Kind: A1
- Application number: 14/490,242
- Filed: 2014-09-18
- Published: 2015-06-25
- Earliest claimed: 2007-07-10
- Assignees: Massachusetts Institute of Technology
- Inventors: Wonshik Choi; Ramachandra Dasari; Christopher Fang-Yen; Michael Feld
- Web page: https://patentgrep.com/patent/US20150177133A1

## CPC

- G01N 21/45: using interferometric methods; using Schlieren methods
- G01N 21/51: inside a container, e.g. in an ampoule (G01N21/53 takes precedence)
- G01N 21/6458: {Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16)}
- G01N 21/6486: {Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence)}
- G03H 1/0443: {Digital holography, i.e. recording holograms with digital recording means (holobject computation G03H1/0866)}
- G03H 1/265: {Angle multiplexing; Multichannel holograms (G03H1/268 takes precedence)}
- G01N 2021/458: {using interferential sensor, e.g. sensor fibre, possibly on optical waveguide}
- G01N 2201/061: Sources
- G01N 2201/105: Purely optical scan
- G01N 2201/12: Circuits of general importance; Signal processing
- G03H 2001/0458: {Temporal or spatial phase shifting, e.g. parallel phase shifting method}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G03H: HOLOGRAPHIC PROCESSES OR APPARATUS (holograms, e.g. point holograms, used as ordinary optical elements G02B5/32; producing stereoscopic or other three-dimensional effects G02B30/00; diffraction-grating systems G02B27/44; systems using moiré fringes G02B27/60; optical logic elements G02F3/00; stereo-photography G03B35/00; photosensitive materials or processes for photographic purposes G03C; {stereo-photographic or similar processes G03C9/00}; apparatus for processing exposed photographic materials G03D; analogue computers performing mathematical operations with the aid of optical elements G06E3/00; authentication by radiation, of concealed information carried by holograms or diffraction gratings G06K19/16; holographic storage G11B7/0065, G11C13/04; {stereoscopic or other three dimensional effects in television systems H04N13/00})

## Abstract

The present invention relates to systems and methods for quantitative three-dimensional mapping of refractive index in living or non-living cells, tissues, or organisms using a phase-shifting laser interferometric microscope with variable illumination angle. A preferred embodiment provides tomographic imaging of cells and multicellular organisms, and time-dependent changes in cell structure and the quantitative characterization of specimen-induced aberrations in high-resolution microscopy with multiple applications in tissue light scattering.

## Claims

### Claim 1

A spatial fringe pattern demodulation method for performing tomographic phase microscopy, the method comprising:
scanning light along a first light path through a medium at a plurality of angles;
combining the light transmitted through the medium with a reference light;
detecting the combined light; and
determining a phase image of the medium using spatial fringe pattern demodulation.

### Claim 2 (depends on 1)

The method of claim 1, further comprising positioning a sample in the medium to be measured relative to the first scanning light path.

### Claim 3 (depends on 2)

The method of claim 2, wherein the sample is a biological sample.

### Claim 4 (depends on 2)

The method of claim 2, wherein an index of refraction of the sample is altered by less than 5%.

### Claim 5 (depends on 4)

The method of claim 4, wherein an index of refraction of the sample is altered by less than 1%.

### Claim 6 (depends on 5)

The method of claim 5, wherein an index of refraction of the sample is not altered.

### Claim 7 (depends on 3)

The method of claim 3, further comprising adding a substance to the medium or to the biological sample prior to said step of determining, wherein adding the substance alters an index of refraction of the biological sample by less than 5%.

### Claim 8 (depends on 7)

The method of claim 7, wherein adding the substance alters an index of refraction of the biological sample by less than 1%.

### Claim 9 (depends on 3)

The method of claim 3, further comprising adding a substance to the medium or to the biological sample prior to said step of determining, wherein adding the substance alters an index of refraction of the biological sample.

### Claim 10 (depends on 3)

The method of claim 3, wherein the biological sample is a cell, a plurality of cells, a tissue, or an organism.

### Claim 11 (depends on 3)

The method of claim 3, wherein the medium is a culture medium.

### Claim 12 (depends on 2)

The method of claim 2, further comprising changing the medium while the sample remains in place.

### Claim 13 (depends on 12)

The method of claim 12, wherein an index of refraction of the sample is not altered.

### Claim 14 (depends on 12)

The method of claim 12, wherein an index of refraction of the sample is altered.

### Claim 15 (depends on 3)

The method of claim 3, wherein phase image of a single cell is measured.

### Claim 16 (depends on 3)

The method of claim 3, wherein an autofluorescence in a single cell is measured.

### Claim 17 (depends on 3)

The method of claim 3, wherein a scattering spectrum in a single cell is measured.

### Claim 18 (depends on 3)

The method of claim 3, wherein a size or volume is measured for the biological sample or a portion thereof.

### Claim 19 (depends on 3)

The method of claim 3, wherein a cell size distribution is measured for the biological sample or a portion thereof.

### Claim 20 (depends on 3)

The method of claim 3, wherein a characteristic of a nucleic acid is measured in the biological sample or a portion thereof.

### Claim 21 (depends on 1)

The method of claim 1, wherein the plurality of angles are in the range from +60 to −60 degrees.

### Claim 22 (depends on 21)

The method of claim 21, further comprising performing a constrained iteration process to supply missing-angle projections.

### Claim 23 (depends on 1)

The method of claim 1, further comprising obtaining a plurality of images of the sample at a rate of at least four frames per second.

### Claim 24 (depends on 23)

The method of claim 23, wherein images of the sample are obtained at a rate of at least 30 frames per second.

### Claim 25 (depends on 1)

The method of claim 1, further comprising determining a distribution of fluorescence in the medium.

### Claim 26 (depends on 25)

The method of claim 25, wherein the medium comprises a biological sample, and the fluorescence is autofluorescence of the sample or is caused by a fluorescent label added to the sample.

### Claim 27 (depends on 1)

The method of claim 1 wherein the transmitted light comprises ultraviolet light.

### Claim 28 (depends on 1)

The method of claim 1 wherein a plurality of different wavelengths of light are transmitted.

### Claim 29 (depends on 1)

A method of diagnosing a disease or medical condition comprising performing the method of claim 1, wherein the medium comprises a cell or tissue sample from a subject suspected of having said disease or medical condition.

### Claim 30 (depends on 29)

The method of claim 29, wherein the subject is suspected of having cancer.

### Claim 31 (depends on 30)

The method of claim 30, wherein the subject is suspected of having cervical or uterine cancer.

### Claim 32 (depends on 31)

The method of claim 31, wherein the cell or tissue sample is positioned in the medium to be measured relative to the first scanning light path, and a change in a refractive index distribution in the sample or a portion thereof is determined after introduction of acetic acid into the medium.

### Claim 33

A tomography system for measuring a medium comprising:
a light source;
a first light path coupling light from the light source onto the medium;
a scanner that scans the first light path through the medium at different angles;
a second light path that couples a reference light onto light transmitted through the medium;
a detector that detects the reference light combined with the light transmitted through the medium; and
a processor that determines a phase image of the medium from the detected light using spatial fringe pattern demodulation.

### Claim 34 (depends on 33)

The tomography system of claim 33 wherein said reference light is enlarged by a beam expander prior to coupling with the light transmitted through the medium.

### Claim 35 (depends on 33)

The tomography system of claim 33 that is capable of determining said phase image of the medium repeatedly at a rate of at least 30 times per second.

### Claim 36 (depends on 33)

The system of claim 33 comprising a microscope.

### Claim 37 (depends on 33)

The system of claim 33 further comprising a second light source for broadband illumination or fluorescence excitation.

### Claim 38 (depends on 37)

The system of claim 37 comprising a second light source for fluorescence excitation and further comprising a second detector that detects fluorescence emission.

### Claim 39 (depends on 33)

The system of claim 33 wherein the first light source is capable of emitting ultraviolet light.

### Claim 40 (depends on 33)

The system of claim 33 wherein the first light source is capable of emitting light at 3 or more distinct wavelengths.

### Claim 41 (depends on 33)

The system of claim 33 wherein the scanner further comprises an actuator and a scanning optical element mounted on the actuator, wherein the actuator moves the scanning optical element to provide the different angles of the first light path through the medium.

### Claim 42

A synthetic aperture method for measuring refractive index of a medium comprising:
transmitting a focused beam of light along a first light path through a medium;
combining the light transmitted through the medium with a reference light;
detecting the combined light;
determining a phase image and an amplitude image of the medium;
combining the phase and amplitude images to form an electrical field image of the medium; and
determining the distribution of a refractive index of the medium using synthetic aperture analysis.

### Claim 43 (depends on 42)

The method of claim 42 wherein the medium is in translational motion and a series of refractive index distributions of the medium are formed.

### Claim 44 (depends on 42)

The method of claim 42, further comprising positioning a sample in the medium to be measured relative to the first scanning light path.

### Claim 45 (depends on 44)

The method of claim 44, wherein the sample is in translational motion and a series of refractive index distributions of the sample are formed.

### Claim 46 (depends on 44)

The method of claim 44, wherein the sample is a biological sample.

### Claim 47 (depends on 44)

The method of claim 44, wherein an index of refraction of the sample is altered by less than 5%.

### Claim 48 (depends on 47)

The method of claim 47, wherein an index of refraction of the sample is altered by less than 1%.

### Claim 49 (depends on 48)

The method of claim 48, wherein an index of refraction of the sample is not altered.

### Claim 50 (depends on 46)

The method of claim 46, further comprising adding a substance to the medium or to the biological sample prior to said step of determining, wherein adding the substance alters an index of refraction of the biological sample by less than 5%.

### Claim 51 (depends on 50)

The method of claim 50, wherein adding the substance alters an index of refraction of the biological sample by less than 1%.

### Claim 52 (depends on 46)

The method of claim 46, further comprising adding a substance to the medium or to the biological sample prior to said step of determining, wherein adding the substance alters an index of refraction of the biological sample.

### Claim 53 (depends on 46)

The method of claim 46, wherein the biological sample is a cell, a plurality of cells, a tissue, or an organism.

### Claim 54 (depends on 46)

The method of claim 46, wherein the biological sample comprises two or more distinct cell types.

### Claim 55 (depends on 46)

The method of claim 46, wherein the medium is a culture medium.

### Claim 56 (depends on 44)

The method of claim 44, further comprising flowing the medium and the sample across the first light path.

### Claim 57 (depends on 46)

The method of claim 46, wherein an index of refraction in a single cell is measured.

### Claim 58 (depends on 46)

The method of claim 46, wherein an autofluorescence in a single cell is measured.

### Claim 59 (depends on 46)

The method of claim 46, wherein a scattering spectrum in a single cell is measured.

### Claim 60 (depends on 46)

The method of claim 46, wherein a size or volume is measured for the biological sample or a portion thereof.

### Claim 61 (depends on 46)

The method of claim 46, wherein a cell size distribution is measured for the biological sample or a portion thereof.

### Claim 62 (depends on 46)

The method of claim 46, wherein a characteristic of a nucleic acid is measured in the biological sample or a portion thereof.

### Claim 63 (depends on 42)

The method of claim 42, further comprising obtaining a plurality of images of the sample at a rate of at least four frames per second.

### Claim 64 (depends on 42)

The method of claim 42, further comprising determining a distribution of fluorescence in the medium.

### Claim 65 (depends on 64)

The method of claim 64, wherein the medium comprises a biological sample, and the fluorescence is autofluorescence of the sample or is caused by a fluorescent label added to the sample.

### Claim 66 (depends on 42)

The method of claim 42, further comprising modulating a frequency of the reference light.

### Claim 67 (depends on 42)

A method of diagnosing a disease or medical condition comprising performing the method of claim 42, wherein the medium comprises a cell or tissue sample from a subject suspected of having said disease or medical condition.

### Claim 68 (depends on 67)

The method of claim 67, wherein the subject is suspected of having cancer.

### Claim 69 (depends on 68)

The method of claim 68, wherein the subject is suspected of having cervical or uterine cancer.

### Claim 70 (depends on 69)

The method of claim 69, wherein the cell or tissue sample is positioned in the medium to be measured relative to the first scanning light path, and a change in a refractive index distribution in the sample is determined after introduction of acetic acid into the medium.

### Claim 71 (depends on 42)

A method of performing flow cytometry, comprising carrying out the method of claim 42, wherein a series of refractive index distributions are determined for a plurality of cells in translational motion.

### Claim 72

A tomography system for phase imaging of a medium comprising:
a first light source;
a first light path coupling light from the light source onto the medium;
a second light path such that a reference light interferes with light transmitted through the medium;
a detector that detects the light transmitted through the medium at different angles; and
a processor that generates a phase image of the medium from the detected light.

### Claim 73 (depends on 72)

The tomography system of claim 72 further comprising a cylindrical lens for focusing light onto the medium.

### Claim 74 (depends on 72)

The tomography system of claim 72 further comprising a cylindrical lens for expanding in focal axis the light transmitted through the medium.

### Claim 75 (depends on 72)

The tomography system of claim 72 further comprising a frequency modulator that modulates a frequency of the reference light.

### Claim 76 (depends on 75)

The system of claim 75 wherein the frequency modulator is an acousto-optic modulator.

### Claim 77 (depends on 75)

The system of claim 75 further comprising a beam expander in the second light path downstream from the frequency modulator.

### Claim 78 (depends on 72)

The system of claim 72 comprising a microscope.

### Claim 79 (depends on 72)

The system of claim 72 further comprising a second light source for broadband illumination or fluorescence excitation.

### Claim 80 (depends on 79)

The system of claim 79 comprising a second light source for fluorescence excitation and further comprising a second detector that detects fluorescence emission.
